Comparison of nintedanib-induced gastrointestinal adverse events in patients with systemic sclerosis-associated interstitial lung disease and idiopathic interstitial pneumonias

被引：0
|
作者：
Imai, Miyu [1 ]
Okabayashi, Hiroko [1 ]
Akaike, Kimitaka [1 ]
Hamada, Shohei [1 ]
Masunaga, Aiko [1 ]
Ichiyasu, Hidenori [1 ]
Sakagami, Takuro [1 ]
机构：
[1] Kumamoto Univ Hosp, Resp Med, Kumamoto, Japan
来源：
RESPIROLOGY | 2023年 / 28卷
关键词：
D O I：
暂无
中图分类号：
R56 [呼吸系及胸部疾病];
学科分类号：
摘要：
AP16-506
引用
收藏
页码：408 / 409
页数：2
相关论文
共 50 条
  • [41] Correspondence on 'Safety and tolerability of nintedanib in patients with systemic sclerosis-associated interstitial lung disease: data from the SENSCIS trial'
    Bredemeier, Markus
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 (12)
  • [42] Tomographic Fibrosis Score in the Patients with Systemic Sclerosis-Associated Interstitial Lung Disease
    Ozmen, Mustafa
    Gumus, Cesur
    Otman, Eda
    Sinci, Kazim Ayberk
    Aysin, Idil Kurut
    Solmaz, Dilek
    Akar, Servet
    EUROPEAN JOURNAL OF RHEUMATOLOGY, 2023, 10 (03) : 107 - 113
  • [43] Efficacy and safety of nintedanib in Asian patients with systemic sclerosis-associated interstitial lung disease: Subgroup analysis of the SENSCIS trial
    Azuma, Arata
    Chung, Lorinda
    Behera, Digambar
    Chung, Melody
    Kondoh, Yasuhiro
    Ogura, Takashi
    Okamoto, Masaki
    Swarnakar, Rajesh
    Zeng, Xiaofeng
    Zou, Heijan
    Meng, Xianhua
    Gahlemann, Martina
    Alves, Margarida
    Kuwana, Masataka
    RESPIRATORY INVESTIGATION, 2021, 59 (02) : 252 - 259
  • [44] Therapeutic effects of thalidomide on patients with systemic sclerosis-associated interstitial lung disease
    Pan, Jie
    Dong, Fei
    Ma, Li
    Zhao, Cheng
    Qin, Fang
    Wen, Jing
    Wei, Wanling
    Lei, Ling
    JOURNAL OF SCLERODERMA AND RELATED DISORDERS, 2023, 8 (03) : 231 - 240
  • [45] EFFECTS OF NINTEDANIB IN PATIENTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD) IN SUBGROUPS BY DISEASE ACTIVITY INDEX
    Herrick, A.
    Pope, J.
    Carreira, P.
    Miede, C.
    Alves, M.
    Allanore, Y.
    ANNALS OF THE RHEUMATIC DISEASES, 2023, 82 : 963 - 963
  • [46] THE STUDY OF THE NINTEDANIB SAFETY PROFILE IN PATIENTS WITH SYSTEMIC SCLEROSIS ASSOCIATED WITH INTERSTITIAL LUNG DISEASE
    Koneva, Olga A.
    Garzanova, Liudmila
    Ananyeva, Lidia
    Ovsyannikova, Olga
    Desinova, Oxana
    Starovoytova, Mayya
    CHEST, 2023, 164 (04) : 5483A - 5484A
  • [47] EFFECTS OF NINTEDANIB ON CIRCULATING BIOMARKERS IN SUBJECTS WITH SYSTEMIC SCLEROSIS-ASSOCIATED INTERSTITIAL LUNG DISEASE (SSC-ILD)
    Assassi, S.
    Kuwana, M.
    Denton, C. P.
    Maher, T.
    Diefenbach, C.
    Ittrich, C.
    Gahlemann, M.
    Distler, O.
    ANNALS OF THE RHEUMATIC DISEASES, 2022, 81 : 719 - 720
  • [48] Effect of nintedanib on circulating biomarkers in subjects with systemic sclerosis-associated interstitial lung disease (SSc-ILD)*
    Prasse, Autoren A.
    Assassi, S.
    Kuwana, M.
    Denton, C.
    Maher, T.
    Diefenbach, C.
    Ittrich, C.
    Gahlemann, M.
    Distler, O.
    PNEUMOLOGIE, 2023, 77 : S53 - S54
  • [49] Expert consensus on the management of systemic sclerosis-associated interstitial lung disease
    Rahaghi, Franck F.
    Hsu, Vivien M.
    Kaner, Robert J.
    Mayes, Maureen D.
    Rosas, Ivan O.
    Saggar, Rajan
    Steen, Virginia D.
    Strek, Mary E.
    Bernstein, Elana J.
    Bhatt, Nitin
    Castelino, Flavia V.
    Chung, Lorinda
    Domsic, Robyn T.
    Flaherty, Kevin R.
    Gupta, Nishant
    Kahaleh, Bashar
    Martinez, Fernando J.
    Morrow, Lee E.
    Moua, Teng
    Patel, Nina
    Shlobin, Oksana A.
    Southern, Brian D.
    Volkmann, Elizabeth R.
    Khanna, Dinesh
    RESPIRATORY RESEARCH, 2023, 24 (01)
  • [50] Serum metabolites as biomarkers in systemic sclerosis-associated interstitial lung disease
    C. Meier
    K. Freiburghaus
    C. Bovet
    J. Schniering
    Y. Allanore
    O. Distler
    C. Nakas
    B. Maurer
    Scientific Reports, 10
12345